BD Life Sciences Preanalytical Systems Product catalogue 2 About BD BD is one of the largest global medical technology companies advance researchers’ capabilities to develop the next in the world and is advancing the world of health by generation of diagnostics and therapeutics. BD has a improving medical discovery, diagnostics and the delivery of presence in virtually every country and partners with care. The company supports the heroes on the frontlines of organisations around the world to address some of the most healthcare by developing innovative technology, services and challenging global health issues. By working in close solutions that help advance both clinical therapy for patients collaboration with customers, BD can help enhance outcomes, and clinical process for healthcare providers. BD and its 65000 lower costs, increase efficiencies, improve safety and expand employees have a passion and commitment to help enhance access to healthcare. In 2017, BD welcomed C. R. Bard and its the safety and efficiency of clinicians’ care delivery process, products into the BD family. enable laboratory scientists to accurately detect disease and BD Business Segments BD Interventional Peripheral Intervention BD Medical Surgery Diabetes Care Urology and Critical Care Medication Delivery Solutions BD Life Sciences Medication Management Solutions Biosciences Pharmaceutical Systems Diagnostics Systems Preanalytical Systems BD European Manufacturing and Distribution Sites Every day millions of BD Vacutainer® Blood Collection Tubes are manufactured in the UK and used worldwide. Plymouth, United Kingdom This plant manufactures the BD Vacutainer® range of products including blood tubes and venous access devices, and supplies markets across Europe and around the world. European Distribution Centre in Temse, Belgium BD in the Benelux plays a major role in the company’s ability Since 2018, the Distribution centre has been expanded with a to meet the growing demand in Eastern and Western Europe, new, highly automated warehouse, bringing the total surface the Middle East and Africa. area covered by BD warehouses up to almost 100000 sq. m. For more information on BD, please visit bd.com. 3 Table of contents About BD 3 The history of BD Vacutainer® systems 6 BD Vacutainer® systems – A story of innovation 6 Patient safety 8 Sample management and analysis 8 The BD specimen collection portfolio ensures safer care during the preanalytical phase 10 BD Laboratory Consulting Services™ – helping deliver better clinical outcomes 11 Venous blood sampling 12 BD Vacutainer® Evacuated Blood Collection System 12 Order of draw 13 Tube dimensions and sample volumes 14 The BD Hemogard™ Safety Closure 15 Coagulation analysis 16 Serum analysis 18 Plasma analysis 23 Haematology 29 Glucose analysis 30 ESR 31 Speciality tubes 32 Cell and biomarker preservation 34 BD CPT™ blood collection tubes 34 BD™ P100 Tubes (for stabilising proteins) 36 BD™ P800 Tubes 37 PAXgene® Blood ccfDNA System 38 PAXgene® Blood RNA System 39 PAXgene® Blood DNA System 40 Blood culture systems 42 BD BACTEC™ Plastic Bottles 42 BD BACTEC™ Media 42 4 Specimen collection and transport system 43 BD™ ESwab™ 43 Safety blood collection sets 44 Safety blood collection needles 50 Accessories 54 Adapter and holder 54 Stretch tourniquets 55 Blood Dispenser 55 Capillary blood sampling 56 Safety lancets 56 BD Microtainer® MAP Tube 58 BD Microtainer® tubes 59 BD Critical Care Collection Syringes 60 Blood gas syringes 60 Urine collection products 62 Transport 64 Additional information 66 Product quality statement 66 Labelling and packaging information 68 Product code index 69 5 BD Vacutainer® systems – A story of innovation 1947 1950 1952 1964 Joseph Kleiner invents First disposable First BD micro lancet is First BD Evacutainer, the start of blood collection set launched (BD Unopette™ Vacutainer® the BD Vacutainer® blood was developed for Products) Heparin collection system journey the Red Cross glass tube is launched 1949 1950 1960 The Evacutainer First glass EDTA, BD opens is patented Serum & Oxalate Broken Bow, NE Vacutainer® tubes manufacturing are launched plant 2002* 2000 1997 1993 ® ® ® BD Vacutainer® Urine BD Vacutainer BD Vacutainer BD Vacutainer ™ Preservative Tube for Stretch latex-free PPT tube is CPT™ tube is urinalysis is launched tourniquet is launched launched launched 2000* 1999 1993 BD Vacutainer® BD Vacutainer® Eclipse™ BD Microtainer® Citrate plastic needle is launched with Quikheel™ lancet 2003* tube is launched safety shield is launched BD Vacutainer® Blood Transfer Device and BD Vacutainer® Luer- Lok™ Access Device (LLAD) are launched 2003 2006 2010 BD Vacutainer® Push BD Microtainer™ BD Microtainer® 2003* Button blood collection Contact Activated MAP EDTA tube BD Vacutainer® set is launched Lancets are launched is launched Eclipse™ blood collection needle with pre- attached holder is launched 2005 2009 BD™ P100 tube and BD Vacutainer® PAXgene® Blood P800 tubes are Learn more at: RNA tube are launched launched bd.com/ 70YrsHealthy 70 years of better outcomes for patients and professionals. 6 systems ® The BD Vacutainer® family of solutions focuses on delivering diagnostic accuracy, a safe environment for patient and healthcare professionals, reduced patient pain, specimen integrity and quality and total cost of ownership. 1970 1975 1979 BD opens Sumter, SC BD launches BD BD Life Sciences- manufacturing plant Vacutainer® SST™ Preanalytical Systems Glass Tube (serum becomes its own separation tube) division, called The history of BD Vacutainer “Vacutainer Systems” 1968 1971 1977 BD launches BD launches BD Microtainer® BD Vacutainer® BD Vacutainer® Urine Tubes are launched Multiple Sample Collection Tubes for small sampling 1980 Straight Needles for culture First BD Vacutainer® Citrate glass tube is launched 1993 1990 1988 BD Vacutainer® BD Vacutainer® plastic tubes 1982 BD launches BD opens CPT™ tube is are launched and most tubes Hemogard™ Plymouth, UK launched are transitioned to plastic closure manufacturing plant 1992* 1988 BD Microtainer® BD Vacutainer® Safety Flow™ Safety-Lok™ blood lancet is launched collection set is launched 2013 2016 2018 BD Sentry™ Safety BD Vacutainer® PAXgene® Blood Lancet is launched Barricor™ blood ccfDNA tube collection tube is is launched launched 2012 2016 2016 2019 BD Vacutainer® Eclipse™ Optimised design – BD Vacutainer® BD Vacutainer® Signal™ blood collection BD Vacutainer® Eclipse™ UltraTouch™ Push Button brand celebrates needle is launched Signal™ blood collection blood collection set 70th birthday needle is launched is launched Thank you for trusting the BD Vacutainer® brand to enable accurate diagnostics that shape the course of care. * Approx. date shown. Varies by region WW 7 Sample management and analysis Driving safe and accurate sample management and analysis throughout the patient journey Did you know the majority of laboratory errors occur during the preanalytical phase?1 About 2/3 "The most commonly performed of laboratory errors occur during invasive medical procedure is wreaking the preanalytical havoc on how patients are being phase 2 diagnosed, medicated and managed." Dennis J. Ernst, Director of the Center for Phlebotomy Education 95% Up to 70% of clinical decisions are based on laboratory data.1 of diagnostic Because of this, laboratory errors have a major delays are the result impact on the diagnostic and treatment pathways. of blood collection errors 3 The preanalytical phase, step by step Preanalytical errors can occur at any step during the process Storage Collection Transportation Sample prep Sample quality Analysis Examples of preanalytical errors Expired tube Patient ID Temperature out Haemolysed sample Incorrect Incorrect label not confirmed of range centrifuge Sample Temperature Syringe collection Non-standard time Insufficient sample Lipaemia > 25°C volume 88 Poor sample quality contributes to errors2 that may: > cause unnecessary patient suffering4 > impact clinical outcomes6 Safety Patient > effect compliance to regulatory standards 3-12 % 160 000 3.3 days patient adverse events Patients spend an extra of hospital laboratory occur in the U.S. 3.3 days at the hospital errors lead to adverse each year because of after a contaminated events 4 misidentification 4 blood culture 5 Impacting patient safety by maximising, improving and standardising sample management and analysis Improve difficult Lean process vein access Improved traceability Shorter fill Optimising time Maximising and Improved clinician standardising sample stability performance workflows, Greater and treatment processes and efficiency Faster lab accuracy procedures response time Improving diagnostic Reduce patient accuracy pain Prevent needlestick injuries Better reliability Better sample quality Less bacterial overgrowth 1. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem. 2002;48(5):691–8 2. Plebani M & Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem. 1997;43(8):1348–135. 3. Zwang O Albert R. Analysis of strategies to improve cost effectiveness of blood cultures.J Hosp Med. 2006;1(5):272–6. 4. College of American Pathologists, Valenstein P, Raab S, Walsh M. Identification errors involving clinical laboratories: a College of American Pathologists Q-Probes study of patient and specimen identification errors at 120 institutions. Arch Pathol Lab Med. 2006;130(8):1106–13. 5. Bush RA, Mueller T, Sumwalt B, Cox SA, Hilfiker ML. Assessing pediatric trauma specimen integrity.Clin Lab Sci. 2010;23(4):219–22.